Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569123 · ClinicalTrials.gov registry record · NA
Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT04569123: Completed NA study, sponsored by Medical University of South Carolina.
NCT04569123 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04569123, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to determine if combining vibration with hand task practice is superior to hand task practice alone.
Primary Outcome
The Wolf Motor Function Test (WMFT) is a standardized, timed assessment of upper extremity motor function. This study reports the total average movement time across the WMFT tasks. Range: 0 seconds to \>120 seconds (no fixed upper limit). Interpretation: Lower movement times indicate better motor function. Only this WMFT movement-time variable was analyzed as the pre-specified primary outcome.
Interventions
- DEVICE real stimulation
- DEVICE No stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2025-01-13 |
| Phase | NA |
What the finished NCT04569123 record still lists
NCT04569123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which real stimulation is the first listed.
NCT04569123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04569123 about?
NCT04569123 is a clinical study titled "Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke". The objective of this study is to determine if combining vibration with hand task practice is superior to hand task practice alone.
What is the current status of trial NCT04569123?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2020-11-02. Estimated completion is 2025-01-13.
What interventions are being tested in trial NCT04569123?
The interventions under investigation include: real stimulation (DEVICE), No stimulation (DEVICE).
Who is sponsoring clinical trial NCT04569123?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04569123's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI